CEO of drugmaker Bristol Myers sees 'real need' for policy reform on prescription pricing
У вашего броузера проблема в совместимости с HTML5
Bristol-Myers Squibb CEO Giovanni Caforio tells Jim Cramer that his company believes the affordability of prescription drugs is a problem. "Medicines are important only when they reach patients," he says.